Cardiotoxicity of anthracyclines.
作者信息
Green M D, Speyer J L, Muggia F M
出版信息
Eur J Cancer Clin Oncol. 1984 Feb;20(2):293-6. doi: 10.1016/0277-5379(84)90200-1.
PMID:6584310
Abstract
摘要
相似文献
1
Cardiotoxicity of anthracyclines.
Eur J Cancer Clin Oncol. 1984 Feb;20(2):293-6. doi: 10.1016/0277-5379(84)90200-1.
2
Anthracyclines in the treatment of acute nonlymphocytic leukemias.蒽环类药物在急性非淋巴细胞白血病治疗中的应用。
Cancer Treat Rep. 1981;65 Suppl 4:73-6.
3
Optimal schedule for anthracyclines.蒽环类药物的最佳给药方案
Eur J Cancer Clin Oncol. 1985 Feb;21(2):159-61. doi: 10.1016/0277-5379(85)90167-1.
4
[Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].[蒽环类药物的心脏毒性。关于12例儿科病例]
Pediatrie. 1981 Sep;36(6):437-50.
5
[Anthracycline cardiotoxicity: review].[蒽环类药物心脏毒性：综述]
Sangre (Barc). 1983;28(1):54-68.
6
Reducing the cardiotoxicity of anthracyclines by complex-binding to DNA: report of three cases.通过与DNA复合结合降低蒽环类药物的心脏毒性：三例报告
Cancer. 1981 Oct 1;48(7):1531-4. doi: 10.1002/1097-0142(19811001)48:7<1531::aid-cncr2820480711>3.0.co;2-4.
7
[Cardiotoxicity of anthracyclines].[蒽环类药物的心脏毒性]
Ann Med Interne (Paris). 1984;135(6):464-72.
8
[One case report of a late cardiotoxicity after administration of low doses of anthracyclines].
Therapie. 2010 May-Jun;65(3):269-70. doi: 10.2515/therapie/2010015. Epub 2010 Aug 11.
9
Aclarubicin: preclinical and clinical data suggesting less chronic cardiotoxicity compared with conventional anthracyclines.阿柔比星：临床前和临床数据表明，与传统蒽环类药物相比，其慢性心脏毒性较小。
Eur J Haematol Suppl. 1987;47:21-31. doi: 10.1111/j.1600-0609.1987.tb00019.x.
10
[Therapy of acute leukemia: contribution of the new anthracyclinic drugs].[急性白血病的治疗：新型蒽环类药物的作用]
Recenti Prog Med. 1985 Jul-Aug;76(7-8):392-7.
引用本文的文献
1
Oxidized phospholipids as potential novel drug targets.氧化磷脂作为潜在的新型药物靶点。
Biophys J. 2007 Nov 1;93(9):3105-12. doi: 10.1529/biophysj.107.103887. Epub 2007 Jun 29.
2
Possible intermediates in the action of adriamycin--a pulse radiolysis study.阿霉素作用过程中的可能中间体——脉冲辐解研究
Br J Cancer. 1985 Apr;51(4):515-23. doi: 10.1038/bjc.1985.74.
Zotero 插件